3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Neoplasms
13
Breast Neoplasms
11
Obesity
8
Motor Activity
7
Malnutrition
7
Colorectal Neoplasms
6
Prostatic Neoplasms
5
Overweight
5
Lung Neoplasms
4
Hypertension
4
Weight Loss
3
Stroke
3
Stomach Neoplasms
3
Pancreatic Neoplasms
3
Heart Failure
3
Diabetes Mellitus
3
Cardiovascular Diseases
3
Sarcopenia
2
Polycystic Ovary Syndrome
2
Osteoporosis
2
Kidney Diseases
2
Inflammation
2
Heart Diseases
2
Gastrointestinal Neoplasms
2
Frailty
2
Endometrial Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Cachexia
2
Arthritis
2
Interventions
fludarabine
2
Busulfan
2
thymoglobulin
1
fludarabine phosphate
1
bicalutamide
1
Testosterone
1
Saline Solution
1
Powders
1
Nutrition Assessment
1
Metformin
1
Mesna
1
Melphalan
1
Influenza Vaccines
1
Honey
1
Heparin
1
Gonadotropin-Releasing Hormone
1
Gastric Bypass
1
Exercise
1
Eating
1
Cyclophosphamide
1
Clofarabine
1
Caloric Restriction
1
Antineoplastic Agents
1
Antilymphocyte Serum
1
Alemtuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Metabolic Diseases
×
Nutrition Assessment
×
Clear all
NCT05432856
2025-08-27
IMPACT-Women
University of Alberta
Phase NA
Recruiting
65 enrolled